Irhythm Technologies [IRTC] vs Penumbra [PEN] Detailed Stock Comparison
Irhythm Technologies
NASDAQ
Loading...
Penumbra
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Irhythm Technologies wins in 5 metrics, Penumbra wins in 13 metrics, with 0 ties. Penumbra appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Irhythm Technologies | Penumbra | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -43.66 | 63.62 | Irhythm Technologies |
| Price-to-Book Ratio | 49.09 | 7.22 | Penumbra |
| Debt-to-Equity Ratio | 708.80 | 17.04 | Penumbra |
| PEG Ratio | -86.14 | 63.62 | Irhythm Technologies |
| EV/EBITDA | -111.34 | 43.56 | Irhythm Technologies |
| Profit Margin (TTM) | -14.06% | 11.54% | Penumbra |
| Operating Margin (TTM) | -5.71% | 21.87% | Penumbra |
| EBITDA Margin (TTM) | N/A | 21.87% | N/A |
| Return on Equity | -91.14% | 12.03% | Penumbra |
| Return on Assets (TTM) | -3.53% | 7.51% | Penumbra |
| Free Cash Flow (TTM) | $-45.55M | $147.30M | Penumbra |
| 1-Year Return | 123.27% | 41.44% | Irhythm Technologies |
| Price-to-Sales Ratio (TTM) | 7.75 | 7.33 | Penumbra |
| Enterprise Value | $5.28B | $9.14B | Penumbra |
| EV/Revenue Ratio | 8.04 | 7.14 | Penumbra |
| Gross Profit Margin (TTM) | 71.17% | 65.99% | Irhythm Technologies |
| Revenue per Share (TTM) | $21 | $33 | Penumbra |
| Earnings per Share (Diluted) | $-2.92 | $3.78 | Penumbra |
| Beta (Stock Volatility) | 1.41 | 0.40 | Penumbra |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Irhythm Technologies vs Penumbra Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Irhythm Technologies | -1.55% | -3.92% | 17.73% | 15.69% | 44.75% | 77.21% |
| Penumbra | -0.10% | -1.04% | -2.95% | -16.71% | -7.88% | 0.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Irhythm Technologies | 123.27% | 4.68% | -8.36% | 514.58% | 514.58% | 514.58% |
| Penumbra | 41.44% | 39.80% | 2.95% | 482.30% | 482.30% | 482.30% |
Performance & Financial Health Analysis: Irhythm Technologies vs Penumbra
| Metric | IRTC | PEN |
|---|---|---|
| Market Information | ||
| Market Cap | $5.09B | $9.39B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 678,940 | 606,920 |
| 90 Day Avg. Volume | 508,497 | 478,647 |
| Last Close | $158.50 | $240.49 |
| 52 Week Range | $55.92 - $168.32 | $164.42 - $310.00 |
| % from 52W High | -5.83% | -22.42% |
| All-Time High | $286.19 (Jan 25, 2021) | $348.67 (Jun 26, 2023) |
| % from All-Time High | -44.62% | -31.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.26% | 0.13% |
| Quarterly Earnings Growth | 0.26% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.12% |
| Operating Margin (TTM) | -0.06% | 0.22% |
| Return on Equity (TTM) | -0.91% | 0.12% |
| Debt to Equity (MRQ) | 708.80 | 17.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.23 | $33.32 |
| Cash per Share (MRQ) | $16.98 | $10.93 |
| Operating Cash Flow (TTM) | $63.35M | $36.77M |
| Levered Free Cash Flow (TTM) | $47.56M | $224.96M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Irhythm Technologies vs Penumbra
| Metric | IRTC | PEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -43.66 | 63.62 |
| Forward P/E | -86.14 | 63.62 |
| PEG Ratio | -86.14 | 63.62 |
| Price to Sales (TTM) | 7.75 | 7.33 |
| Price to Book (MRQ) | 49.09 | 7.22 |
| Market Capitalization | ||
| Market Capitalization | $5.09B | $9.39B |
| Enterprise Value | $5.28B | $9.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.04 | 7.14 |
| Enterprise to EBITDA | -111.34 | 43.56 |
| Risk & Other Metrics | ||
| Beta | 1.41 | 0.40 |
| Book Value per Share (MRQ) | $3.23 | $33.32 |
Financial Statements Comparison: Irhythm Technologies vs Penumbra
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IRTC | PEN |
|---|---|---|
| Revenue/Sales | $158.68M | $324.14M |
| Cost of Goods Sold | $49.46M | $108.26M |
| Gross Profit | $109.22M | $215.88M |
| Research & Development | $21.82M | $22.08M |
| Operating Income (EBIT) | $-32.56M | $40.35M |
| EBITDA | $-20.95M | $49.20M |
| Pre-Tax Income | $-30.04M | $43.86M |
| Income Tax | $665,000 | $4.64M |
| Net Income (Profit) | $-30.70M | $39.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IRTC | PEN |
|---|---|---|
| Cash & Equivalents | $375.28M | $376.05M |
| Total Current Assets | $636.01M | $999.71M |
| Total Current Liabilities | $111.34M | $158.63M |
| Long-Term Debt | $719.36M | $205.85M |
| Total Shareholders Equity | $86.67M | $1.21B |
| Retained Earnings | $-789.60M | $99.23M |
| Property, Plant & Equipment | $55.71M | $274.92M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IRTC | PEN |
|---|---|---|
| Operating Cash Flow | $-31.20M | $46.01M |
| Capital Expenditures | $-9.42M | $-13.47M |
| Free Cash Flow | $-17.31M | $35.50M |
| Debt Repayment | $0 | $-613,000 |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IRTC | PEN |
|---|---|---|
| Shares Short | 2.49M | 1.83M |
| Short Ratio | 5.55 | 4.26 |
| Short % of Float | 0.09% | 0.07% |
| Average Daily Volume (10 Day) | 678,940 | 606,920 |
| Average Daily Volume (90 Day) | 508,497 | 478,647 |
| Shares Outstanding | 31.39M | 38.49M |
| Float Shares | 31.74M | 37.66M |
| % Held by Insiders | 0.01% | 0.04% |
| % Held by Institutions | 1.14% | 0.92% |
Dividend Analysis & Yield Comparison: Irhythm Technologies vs Penumbra
| Metric | IRTC | PEN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |